BREAKOUT CONTROL BLEMISH TREATMENT FACIAL LOTION
BREAKOUT CONTROL BLEMISH TREATMENT FACIAL LOTION, NPN 80086647: natural health product licensed in Canada. Medicinal ingredients: Acide 2-hydroxybenzoïque.
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide 2-hydroxybenzoïque Source : Acide salicylique | 1.5 % |
Non-medicinal ingredients
Alcool stéarylique, Polymère croisé d'acrylates/acrylate d'alkyle en C10 à 30, Gomme de xanthane, Jus de feuilles d'Aloe Barbadensis, Acide octadécène dioïque, Aqua, Di-C12-13 Alkyl malate, Extrait de racine de Zingiber Officinale (Gingembre), NA, PCA de zinc, Niacinamide, Citral, Acide citrique, Octénylsuccinate d'amidon aluminium, Alcool myristylique, Stéarate de PEG-100, Cyclohexasiloxane, Hydroxyde de sodium, Acide capryloyl salicylique, Benzoate de sodium, Propylène glycol, Sorbate de potassium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | 1 Lotion | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
For the treatment/management of acne. Helps prevent new acne pimples from forming.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For external use only. Keep out of reach of children. If swallowed, call a Poison Control Centre or get medical help right away. Skin irritation and dryness are more likely to occur when using another topical acne product at the same time. If irritation occurs, use only one product at a time. Avoid contact with eyes; if contact occurs, rinse thoroughly with water. For more severe cases, and/or if improvement is not apparent within 6-8 weeks, consult a health care professional.
- Effets indésirables connus
If you develop severe irritation, burning or itching of the skin, discontinue use and consult a health care professional. If you develop hives, swelling of eyes and mouth, blistering or difficulty breathing, get medical help right away.
Product record
- Licence holder
- Kiehl's Canada
- NPN or DIN-HM
- 80086647
- Status
- Inactive licence
- Licence date
- 27 June 2018
- Revision date
- Not provided
- Form
- Lotion
- Route of administration
- Topique
- Application type
- Officinale
Source
Official Health Canada record, licence 80086647
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “BREAKOUT CONTROL BLEMISH TREATMENT FACIAL LOTION (Kiehl's Canada): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80086647-breakout-control-blemish-treatment-facial-lotion, updated 27 June 2018.